This combination produced impressive response and disease control rates with good tolerability in treatment-naive patients with advanced melanoma.

Exciting research presented at ESMO 2017 will likely affect clinical practice in metastatic prostate cancer, says Dr Johann de Bono.

A new analysis proves that the Massachusetts health insurance 'experiment' resulted in better cancer care.

At the ESMO 2017 Congress in Madrid, Drs Sobrero and Taieb discuss the optimal duration of adjuvant chemotherapy for stage III colon cancer.

Combination treatments are escalating already urgent questions about the cost and value of new cancer drugs.

At ESMO 2017, Jack West discussed new, potentially practice-changing immunotherapy research with Hossein Borghaei and Sanjay Popat.

Drs West, Garon, and Borghaei discuss immunotherapy for selected lung cancers and the potential roles and pitfalls of combination immunotherapy.

Dr Banerjee discusses advances in ovarian and cervical cancers presented at ESMO 2017.

Oncologists fail to recommend HPV vaccination to young cancer survivors, even though it is a safe and effective cancer prevention strategy.

Dealing with the hype has to do with putting accurate information on the table for discussion, getting rid of the taboos of conversation, and increasing transparency, says Dr Leonard Saltz.